A proof of principle investigation of a novel enzyme formulation on dental calculus deposition: a 4-week randomized human clinical trial

Background The dissolution of dental calculus, safely and at home, is among the more challenging issues facing the over-the-counter healthcare industry. Pontis Biologics, Inc. has developed novel model of calculus development and structure and has formulated a dentifrice (Tartarase™) using digestive...

Full description

Saved in:
Bibliographic Details
Published in:BMC oral health Vol. 24; no. 1; pp. 720 - 8
Main Authors: Milleman, Kimberly R., Deener, Greg, Milleman, Jeffery L., Mish, Barbara, Schuller, Reinhard, Mynarcik, Dennis
Format: Journal Article
Language:English
Published: London BioMed Central 22.06.2024
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
Adult
Adverse
Biofilms
Brushing
Calculus
Cardiovascular disease
Care and treatment
Clinical trials
Control
Dental calculus
Dental Calculus - prevention & control
Dental caries
Dental plaque
Dentifrices - therapeutic use
Dentistry
Diabetes
Diagnosis
Digestive enzymes
Disease prevention
Enzymes
Female
Fluorides
Health aspects
Humans
Hygiene
Identification and classification
Male
Medicine
Microbial mats
Middle Aged
Mouth diseases
Oral and Maxillofacial Surgery
Oral diseases
Oral hygiene
Proof of Concept Study
Safety
Teeth
Toothbrushing
Toothpaste
Volpe-Manhold Index (V-MI)
Canada
United States > US
Enzymes
Volpe-Manhold Index (V-MI)
Formulation
Brushing
Calculus
Adverse
Safety
ISSN:1472-6831, 1472-6831
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The dissolution of dental calculus, safely and at home, is among the more challenging issues facing the over-the-counter healthcare industry. Pontis Biologics, Inc. has developed novel model of calculus development and structure and has formulated a dentifrice (Tartarase™) using digestive enzymes as active ingredients that is shown to dissolve dental calculus in this Proof of Principle clinical trial. Methods This investigation was designed to evaluate the safety and efficacy of a novel enzyme formulation to remove existing calculus deposits in 4 weeks, measured using the Volpe-Manhold Index (V-MI) on lingual surfaces of 6 lower anterior teeth. The test formulation was compared to Crest Cavity Protection, as a control dentifrice. A total of 40 randomized test subjects began the study with 20 assigned to the control dentifrice and 20 assigned to the Tartarase groups (ten each, one brushing with Tartarase twice daily and one brushed with Tartarase and wore a dental tray filled with Tartarase for 30 min then brushed again with Tartarase, once daily). Results The Crest group experienced a 12% increase in calculus, in contrast to the results of both Tartarase groups that experienced a 40% reduction in calculus in 4 weeks of unsupervised at home use of the Tartarase toothpaste formulation. Conclusions This proof of principle study demonstrates that a dentifrice, formulated along the lines of the Tartarase material, is capable of combating calculus accumulation using the same oral hygiene habits that are common worldwide. Trial registration This trial was registered retrospectively at clinicaltrials.gov and has the Unique Identification Number: NCT06139835, 14/11/2023.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1472-6831
1472-6831
DOI:10.1186/s12903-024-04498-x